Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |